Search Results - "Gomez-Roca, C. A."

AUTHOR INDEX.

Source: Asia Pacific Journal of Clinical Oncology. Nov2017 Supplement S5, Vol. 13, p225-235. 11p.

Signalomics for molecular tumor boards and precision oncology of breast and gynecological cancers.

Authors: Denisenko, Tatiana V Ivanova, Anna E Koval, Alexey et al.

Source: Molecular Systems Biology. Aug2025, Vol. 21 Issue 8, p952-959. 8p.

Therapeutic Potential of an Anti-CD44v6 Monoclonal Antibody in Xenograft Models of Colorectal and Gastric Cancer.

Authors: Hirayama, Aoi Tanaka, Tomohiro Ohishi, Tomokazu et al.

Source: Cells (2073-4409). Dec2025, Vol. 14 Issue 23, p1873. 14p.

The efficacy of Pembrolizumab, Ipilimumab, and Nivolumab monotherapy and combination for colorectal cancer: A systematic review and meta-analysis.

Authors: Adrianto, Albertus Ari Riwanto, Ignatius Sadhana, Udadi et al.

Source: PLoS ONE. 11/14/2025, Vol. 20 Issue 11, p1-19. 19p.

Constitutive RLI Armoring Enhances CAR-NK Cell Effector Functions but Causes Lethal Toxicity In Vivo.

Authors: Ling, Zhiming Wang, Yi Wu, Geping et al.

Source: International Journal of Molecular Sciences. Apr2026, Vol. 27 Issue 8, p3554. 22p.

Molecular and Cellular Basis of Oral Lichen Planus: Bridging Pathogenesis and Modern Clinical Paradigms.

Authors: Kumagai, Kenichi Kishi, Yuta Suzuki, Taiki et al.

Source: International Journal of Molecular Sciences. Apr2026, Vol. 27 Issue 8, p3444. 11p.

Role of Cytokines in Oligometastatic Non-Small-Cell Lung Cancer Treated with Stereotactic Radiation Therapy: An Observational Pilot Study.

Authors: Facheris, Giorgio Bruni, Alessio Nardone, Valerio et al.

Source: Biomolecules (2218-273X). Mar2026, Vol. 16 Issue 3, p423. 16p.

Pre-Existing Immunity Shapes Cancer Immunotherapy Efficacy.

Authors: Xagara, Anastasia Koinis, Filippos Tsapakidis, Konstantinos et al.

Source: Onco. Mar2026, Vol. 6 Issue 1, p4. 14p.

Surufatinib plus anti‐PD‐1/PD‐L1 antibody as second‐line therapy for advanced biliary tract cancer: A single‐centre investigator‐initiated trial.

Authors: Chen, Xinni Wang, Feng Cheng, Yuan et al.

Source: Clinical & Translational Discovery. Feb2026, Vol. 6 Issue 1, p1-11. 11p.

Long-Term Complete Response to Pembrolizumab in Tumor Mutation Burden-High Small Cell Lung Cancer: A Case Report.

Authors: Komuta, Kiyohide Kunimasa, Kei Miyazaki, Akito et al.

Source: Case Reports in Oncology. 2025, Vol. 18 Issue 1, p451-456. 6p.

NUT carcinoma of larynx with aberrant LCA expression: A rare entity with diagnostic and therapeutic challenge.

Authors: Arora, Vikas Pasricha, Sunil Kumar, Ankur et al.

Source: Journal of Cancer Research & Therapeutics. Jan-Mar2025, Vol. 21 Issue 1, p311-314. 4p.

Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma.

Authors: Wang, Qian Xu, Chunwei Wang, Wenxian et al.

Source: Thoracic Cancer. Sep2023, Vol. 14 Issue 26, p2715-2731. 17p.

THBS3 Functions as a Novel Biomarker for Prognosis and Immunotherapeutic Response in Colorectal Cancer: An Integrative Analysis and Validation of the Thrombospondin Gene Family.

Authors: Jiang, Tao Zhu, Sichao Zhou, Hengyi et al.

Source: Cancer Informatics. 1/27/2026, Vol. 25, p1-16. 16p.

Tumor Growth Rate Predicts Pathological Outcomes in Breast Fibroepithelial Tumors: A Pilot Study and Review of Literature.

Authors: Bahmad, Hisham F. Falcon, Adriana Araji, Abdallah et al.

Source: Cancers. Jan2026, Vol. 18 Issue 2, p269. 16p.

Correction: Hassel et al. Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition. Cancers 2023, 15 , 3448.

Authors: Hassel, Jessica C. Zimmer, Lisa Sickmann, Thomas et al.

Source: Cancers. Dec2025, Vol. 17 Issue 23, p3726. 13p.

Tracheal resection and reconstruction under non-intubated anesthesia for nuclear protein in testis carcinoma: a case report.

Authors: Li, Zijian Wang, Chudong Li, Yuxuan et al.

Source: World Journal of Surgical Oncology. 5/14/2025, Vol. 23 Issue 1, p1-6. 6p.

Identification of microenvironment features associated with primary resistance to anti-PD-1/PD-L1 + antiangiogenesis in gastric cancer through spatial transcriptomics and plasma proteomics.

Authors: Cousin, Sophie Guégan, Jean-Philippe Shitara, Kohei et al.

Source: Molecular Cancer. 9/13/2024, Vol. 23 Issue 1, p1-11. 11p.

A Bayesian design with efficient backfilling and expansion to accelerate phase I/II trials accommodating late-onset competing risk outcomes.

Authors: Qiu, Yingjie Li, Mingyue

Source: Statistics in Biopharmaceutical Research. Jul2026, p1-20. 20p. 3 Illustrations.

Intra-Tumor Heterogeneity of Pancreatic Ductal Adenocarcinoma (PDAC)—Microenvironmental Interaction and Precision Immunotherapy Strategies: A Multi-Omics-Based Integrated Perspective.

Authors: Kim, Boyeon Lee, Jee-Hyung

Source: International Journal of Molecular Sciences. Jul2026, Vol. 27 Issue 13, p5682. 32p.

Beyond PD-1/PD-L1: Reprogramming the Gynecologic Tumor Microenvironment by Targeting TIGIT and Myeloid Suppression.

Authors: Waseem, Shanza Zhan, Jun Xiao, Xue

Source: International Journal of Molecular Sciences. Jun2026, Vol. 27 Issue 12, p5373. 25p.